These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


367 related items for PubMed ID: 3137258

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
    Sampson-Johannes A, Carlino JA.
    J Immunol; 1988 Nov 15; 141(10):3680-6. PubMed ID: 3053901
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
    Heidenreich S, Gong JH, Schmidt A, Nain M, Gemsa D.
    J Immunol; 1989 Aug 15; 143(4):1198-205. PubMed ID: 2473121
    [Abstract] [Full Text] [Related]

  • 6. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
    Hancock WW, Pleau ME, Kobzik L.
    J Immunol; 1988 May 01; 140(9):3021-5. PubMed ID: 3129507
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes.
    Hart PH, Whitty GA, Piccoli DS, Hamilton JA.
    Immunology; 1989 Mar 01; 66(3):376-83. PubMed ID: 2495247
    [Abstract] [Full Text] [Related]

  • 11. Interleukin 1 and/or tumor necrosis factor-alpha synergize with granulocyte-macrophage colony-stimulating factor to enhance histamine synthesis in hematopoietic cells: role of prostaglandin E2.
    Piquet-Pellorce C, Homo-Delarche F, Dy M.
    Eur J Immunol; 1989 Nov 01; 19(11):1999-2003. PubMed ID: 2689185
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S, Kreuzfelder E, Waydhas C, Schade FU, Flohé S.
    Inflamm Res; 2007 Jan 01; 56(1):38-44. PubMed ID: 17334669
    [Abstract] [Full Text] [Related]

  • 17. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
    Kleinerman ES, Knowles RD, Lachman LB, Gutterman JU.
    Cancer Res; 1988 May 01; 48(9):2604-9. PubMed ID: 3128401
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of macrophage activation by IL-3. II. IL-3 and lipopolysaccharide act synergistically in the regulation of IL-1 expression.
    Frendl G, Fenton MJ, Beller DI.
    J Immunol; 1990 May 01; 144(9):3400-10. PubMed ID: 2109777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.